Samaha, R.; El Sayed, R.; Alameddine, R.; Florescu, M.; Tehfe, M.; Routy, B.; Elkrief, A.; Belkaid, W.; Desilets, A.; Weng, X.;
et al. Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study). Curr. Oncol. 2025, 32, 57.
https://doi.org/10.3390/curroncol32020057
AMA Style
Samaha R, El Sayed R, Alameddine R, Florescu M, Tehfe M, Routy B, Elkrief A, Belkaid W, Desilets A, Weng X,
et al. Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study). Current Oncology. 2025; 32(2):57.
https://doi.org/10.3390/curroncol32020057
Chicago/Turabian Style
Samaha, Ramy, Rola El Sayed, Raafat Alameddine, Marie Florescu, Mustapha Tehfe, Bertrand Routy, Arielle Elkrief, Wiam Belkaid, Antoine Desilets, Xiaoduan Weng,
and et al. 2025. "Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study)" Current Oncology 32, no. 2: 57.
https://doi.org/10.3390/curroncol32020057
APA Style
Samaha, R., El Sayed, R., Alameddine, R., Florescu, M., Tehfe, M., Routy, B., Elkrief, A., Belkaid, W., Desilets, A., Weng, X., Nassabein, R., Blanc-Durand, F., Kenth, G., Kasymjanova, G., Agulnik, J., & Blais, N.
(2025). Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study). Current Oncology, 32(2), 57.
https://doi.org/10.3390/curroncol32020057
